FDA Drug recall D-0276-2022
Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/325 mg, 100-count bottle, Rx only, Manufactured for: Camber Pharmaceuticals, Inc
- FDA Drug
- Class II
- terminated
- Published 2021-12-15
On 2021-12-15 the FDA classified a Class II recall of Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/325 mg, 100-count bottle, Rx only, Manufactured for: Camber Pharmaceuticals, Inc by Ascent Pharmaceuticals, citing product Mix-up.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0276-2022 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2021-11-19 |
| Published | 2021-12-15 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Ascent Pharmaceuticals |
| Distribution | US |
Product
Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/325 mg, 100-count bottle, Rx only, Manufactured for: Camber Pharmaceuticals, Inc. Piscataway, NJ 08854, Manufactured by: Ascent Pharmaceuticals, Inc., Central Islip, NY 11722, NDC 31722-997-01.
Reason
Product Mix-up
Identifiers
| ndc | 31722-996-01 |
|---|---|
| ndc | 31722-996-05 |
| ndc | 31722-997-01 |
| ndc | 31722-997-05 |
| code_info | Lot #: 21070817, Exp 6/2023 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0276-2022%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.